We further investigated the clinical impact of DNMT3A variant allele frequency (VAF) and two different comutated genetypes on these patients, which might help to further refine biological and prognostic implications of DNMT3A mutations in de novo CN‐AML. Here, DNMT3A is linked to acute myeloid leukemia.